Patent · US Active

Crystal form and salt form of and preparation method for tyrosine kinase inhibitor

US10766862B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

GUANGDONG RAYNOVENT BIOTECH CO., LTD. · CN

Inventors

Chaofeng Long · Tangxia, CN
Zhengxia Chen · Shanghai, CN
Xiaoxin Chen · Cupertino, US
Yang Zhang · San Diego, US
Zhuowei Liu · 流花街道, CN
Shuhui CHEN · Shanghai, CN
Jian Li · Shanghai, CN

Key dates

Filing date	Sep 29, 2017
Grant date	Sep 8, 2020
Priority date	—
Expiry date	Sep 29, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a crystal form and a salt form of and a preparation method for a tyrosine kinase inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.